S. Martin

Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis

D. Ni, B. Oh, T. Kowalik, 2011, Cell Death and Differentiation.

Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes

C. D. Salcido, N. Caplen, S. Bates, 2008, British Journal of Cancer.

Muir-Torre-like syndrome in Fhit-deficient mice.

C. Croce, R. Mancini, K. Huebner, 2000, Proceedings of the National Academy of Sciences of the United States of America.

RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.

Y. Pommier, N. Caplen, R. Guha, 2011, Current cancer drug targets.

Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.

S. Martin, M. Yu, L. Roman, 1998, Journal of the National Cancer Institute.

WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance

C. Deng, Xiaoling Xu, F. Shao, 2017, Scientific Reports.